Ribonexus
PrivateLast Round
Grant
Apr 12, 2022
Total Funding Raised
$6.89M
Company Overview
Ribonexus operates in Healthcare & Life Sciences and is based in Villejuif. Its latest recorded funding round was a Grant round in April 2022.
Ribonexus is a biotechnology company that develops therapies to overcome resistance to current targeted treatments in cancer patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ribonexus Comparables
Compare Ribonexus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SJP Biotec GmbH | 82% | |
| PIC Therapeutics | 80% | |
| Ribometrix | 75% |
For institutional investors. Book with your work email.
Ribonexus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 12, 2022 | ||||
| Seed | Sep 27, 2021 |
For institutional investors. Book with your work email.
Ribonexus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Crédit Mutuel Innovation | Seed |
| Bpifrance | Grant |
| AdBio partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 12, 2022
$2.19M grant round from Bpifrance.
- Sep 27, 2021
$4.7M round led by Advent France Biotechnology
For institutional investors. Book with your work email.
Ribonexus Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ribonexus's valuation, stock price, and market status.
Is Ribonexus a public or private company?
Ribonexus is a private company.
What is the current stock price of Ribonexus?
Ribonexus is a private company, so its shares have no public market price. Caplight tracks Ribonexus's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ribonexus worth (valuation)?
Valuation information for Ribonexus is not publicly available.
Can I buy Ribonexus stock?
Ribonexus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ribonexus's last funding round?
Ribonexus's most recent funding round was Grant on April 12, 2022.
Who are the main investors in Ribonexus?
Key investors in Ribonexus include AdBio partners.
Will Ribonexus IPO soon?
No public IPO plans have been announced for Ribonexus.
How can I track Ribonexus secondary market activity?
Caplight tracks bids, offers, and trades in Ribonexus's shares on secondary markets.